Eric Durbin

University Of Kentucky

$18,123,119

Attributed

$18,123,119

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $3.5M · FY2019–25

$5M$3.8M$2.5M$1.3M$0

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$18,123,119 · 3

By mechanism

N01$17,756,297 · 1

N02$366,822 · 2

Top collaborators

No co-investigators on record.

Most similar at University Of Kentucky

Same institution · by research overlap

Thomas Tucker$13,374,965
Sharon L. Walsh$101,480,172
Susanne M Arnold$5,854,444
Carl G Leukefeld$17,186,902
Cynthia Lynn Gaskill$692,989

Others in their field

Other Emerging Leaders on “Malignant Neoplasms”

Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Leonard Freedmand · Leidos Biomedical Research, Inc.$108,968,336
Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
Martha Hering · Westat, Inc.$57,098,843

Research focus

Malignant NeoplasmsDiagnosisNational Cancer InstituteIncidenceCancer PatientSeer ProgramPatternAnnual ReportsInfrastructurePrevalenceCancer StatisticsTrendSocial CharacteristicsMonitorGeographyCancer ControlInsightSubgroupTreatment PatternComorbidityEthnic OriginInsurance CoverageEducational Process Of InstructingCharacteristics